Ilyang Pharm (007570)

Currency in KRW
7,300
+60(+0.83%)
Closed·
Advertisement
007570 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
7,1707,450
52 wk Range
7,13016,240
Key Statistics
Bid/Ask
7,260.00 / 7,310.00
Prev. Close
7,240
Open
7,240
Day's Range
7,170-7,450
52 wk Range
7,130-16,240
Volume
22.86K
Average Volume (3m)
20.01K
1-Year Change
-44.0613%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
007570 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Ilyang Pharm News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Earnings

Latest Release
14/08/2026
EPS / Forecast
-134.00 / --
Revenue / Forecast
65.14B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 946.42
Dividend Yield
2.14%
Industry Median 1.13%
Annualised payout
155.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 007570 to Peers and Sector

Metrics to compare
007570
Peers
Sector
Relationship
P/E Ratio
8.0x8.2x−0.3x
PEG Ratio
0.110.030.00
Price/Book
0.5x0.7x2.6x
Price / LTM Sales
0.5x0.7x2.9x
Upside (Analyst Target)
-66.4%67.3%
Fair Value Upside
Unlock26.8%10.3%Unlock

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and beverages. In addition, the company offers pharmaceutical raw materials products, such as aluminum hydroxide gel, dried aluminum hydroxide gel, magnesium hydroxide, magnesium hydroxide gel, aluminum hydroxide-magnesium carbonate co-dried gel, magnesium trisilicate, hydrotalcite, almagate, aluminum phosphate, aluminum phosphate gel, aluminum magnesium metasilicate, aluminum magnesium silicate, aluminum magnesium silicopolydrate, magaldrate, magaldrate wet gel, dihydroxy aluminum sodium carbonate, magnesium carbonate, aluminum magnesium hydroxide, synthetic aluminum silicate, and other products. Ilyang Pharmaceutical Co.,Ltd also exports its products. The company was formerly known as Il-Yang Pharm. Ind. Co. and changed its name to Ilyang Pharmaceutical Co., Ltd. in May 1991. Ilyang Pharmaceutical Co.,Ltd was founded in 1946 and is headquartered in Yongin-si, South Korea.

Employees
660

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
150.42K0.84%1.13B
Other Institutional Investors
1.50K0.01%11.25M
Public Companies & Retail Investors
17.77M99.15%133.30B
Total
17.92M100.00%134.44B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dimensional Fund Advisors LP0.78%140,2541,051,905
DFA Investment Dimensions Group Inc. - Emerging Markets Core Equity 2 Portfolio0.38%68,616514,620

People Also Watch

65,600
103590
+0.31%
60,300
004490
+0.84%
19,490
030000
+0.52%
2,545
003620
+2.00%
65,500
006120
+2.83%

FAQ

What Is the Ilyang Pharm (Seoul: 007570) Share Price Today?

The Ilyang Pharm stock price today is 7,300 KRW.

What Stock Exchange Does Ilyang Pharm (007570) Trade On?

Ilyang Pharm is listed and trades on the Seoul Stock Exchange.

What Is the Ticker (Stock Symbol) for Ilyang Pharm?

The stock symbol (also called a 'ticker') for Ilyang Pharm is "007570."

Does Ilyang Pharm Pay Dividends? What’s The Current 007570 Dividend Yield?

Yes, 007570 Pays Dividends to its Shareholders. The current Ilyang Pharm dividend yield is 2.1%%.

What Is the Current Ilyang Pharm Market Capitalisation?

As of today, Ilyang Pharm (Seoul: 007570) market cap is 130.85B KRW.

What Is Ilyang Pharm's (007570) Earnings Per Share (TTM)?

The Ilyang Pharm EPS is currently 946.42 (Trailing Twelve Months).

Is 007570 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Ilyang Pharm moving averages and other technical indicators, the daily buy/sell signal for 007570 stock is Strong Sell.

How Many Times Has Ilyang Pharm Stock Split?

Ilyang Pharm has split 5 times. (See the 007570 stock split history page for full effective split date and price information.)

How Many Employees Does Ilyang Pharm Have?

Ilyang Pharm has 660 employees, based on their latest Companies House report.

What is the current trading status of Ilyang Pharm (Seoul: 007570)?

As of 17/10/2026, Ilyang Pharm (007570) is trading at a share price of 7,300 KRW, with a previous close of 7,240 KRW. The stock has fluctuated within a day range of 7,170 KRW to 7,450 KRW, while its 52-week range spans from 7,130 KRW to 16,240 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.